Data from Increased Interaction between B Cells and CD3+ T Cells in Nonprogressors with Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma
Tumor-infiltrating lymphocytes are associated with a decreased risk of recurrence in human papillomavirus–associated oropharyngeal squamous cell carcinoma. The composition and spatial distribution of tumor-infiltrating lymphocytes and tumor-infiltrating immune cells are not well characterized.
Experimental Design:Formalin-fixed, paraffin-embedded primary and lymph node (LN) tumor tissues from 10 progressors (cases) and 10 matched nonprogressors (controls) were interrogated by imaging mass cytometry. Immune, stromal, and tumor cells were quantified from selected regions of interest using machine learning. Nearest neighbors, cell–cell interactions, and niche analyses were performed.
Results:In primary regions of interest, immune cell, lymphocyte, T cell, CD8+ T cell, and innate cell prevalence was significantly greater in controls. High prevalence of immune cells, lymphocytes, innate cells, and CD4+ T cells in primary tissues was significantly associated with increased time to event (TTE). Although primary and LN prevalence of T cells, CD4+ T cells, CD8+ T cells, macrophages, and tumor cells were significantly correlated, differences in LNs were neither significant nor associated with TTE. Average distances between T cells and the nearest B cells and between lymphocytes and the nearest tumor cells were decreased in control primary tissues. Interactions between B and T cells were less organized in primary tissues from cases. A niche predominantly comprising lymphocytes was associated with longer TTE.
Conclusions:In human papillomavirus–associated oropharyngeal squamous cell carcinoma, immune cell subset prevalence in primary tumors differs with outcome and is associated with TTE. Interactions between B cells and both T-cell subsets are associated with longer TTE, underscoring the importance of active intratumoral immune responses in outcomes.
CITE THIS COLLECTION
FUNDING
Mayo Clinic Eagles District Cancer Telethon Funds Available for Cancer Research Fund - Fellowship
Paul Calabresi Program in Clinical/Translational Research at the Mayo Clinic Comprehensive Cancer Center
Mayo Clinic Comprehensive Clinical Cancer Center
SHARE
Usage metrics

AUTHORS (12)
- KBKathleen R. BartemesRMRaymond M. MooreBNBrenna C. NovotnyKPKevin D. PavelkoWSWill A. ShermanMRMichael RiveraJGJoaquin J. GarciaLYLinda X. YinDMDaniel J. MaEMEric J. MooreKVKathryn M. Van AbelDRDavid M. Routman